Dermatology Times: SDPA Summer 2025 Edition

123456789101112131415161718
Across
  1. 3. Amy Spizuoco, DO, FAOCD, presented on how this technique supports hair loss diagnosis.
  2. 8. This talk series spotlighted leadership, advocacy, and industry CV reviews for PAs.
  3. 10. A color wheel method was shared to improve diagnostic confidence in this visual diagnostic tool.
  4. 13. Sally Santos, PhD, PA-C, covered advanced cosmetic techniques including the use of these injectable agents.
  5. 14. Cynthia Griffith, MPAS, PA-C, discussed career-building and publication opportunities through this journal.
  6. 16. Janelle Ball offered strategies to improve success with these time-consuming insurance requirements.
  7. 18. Eileen Cheever, MPAS, PA-C, led a session that highlighted facts about this family of intracellular signaling proteins.
Down
  1. 1. This IL-36 receptor inhibitor showed durable results in a high-risk patient with GPP.
  2. 2. This oral PDE4 inhibitor showed efficacy across BMI spectrums for early oligoarticular PsA.
  3. 4. DFD-29 outperformed doxycycline in this inflammatory facial condition.
  4. 5. An evening symposium explored clinical insights and management strategies for this pigmentary disorder.
  5. 6. These cosmetic injectables were part of a session on basics to advanced dermatologic techniques.
  6. 7. “Fear No Hives” shared new insights into spontaneous chronic forms of this itchy condition.
  7. 9. Skin signs led to the early detection of this serious cancer progression.
  8. 11. Several tracks, including “Behind the Flare,” explored this science behind chronic inflammatory diseases.
  9. 12. Spesolimab and TYK2 inhibitors were among the therapies highlighted for this chronic disease.
  10. 15. Adam Friedman, MD, FAAD, emphasized a stepwise approach to treating chronic eczema located here.
  11. 17. This kinase target is associated with next-generation treatments for plaque psoriasis.